We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

346 hedge funds and large institutions have $7.99B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 120 increasing their positions, 112 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 112

2% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 94

1% less funds holding

Funds holding: 348 → 346 (-2)

24% less capital invested

Capital invested by funds: $10.6B → $7.99B (-$2.57B)

26% less funds holding in top 10

Funds holding in top 10: 19 → 14 (-5)

41% less call options, than puts

Call options by funds: $231M | Put options by funds: $389M

Holders
346
Holders Change
-2
Holders Change %
-0.57%
% of All Funds
9.23%
Holding in Top 10
14
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-26.32%
% of All Funds
0.37%
New
96
Increased
120
Reduced
112
Closed
94
Calls
$231M
Puts
$389M
Net Calls
-$158M
Net Calls Change
-$27.2M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$703M
2
JHIU
Janus Henderson Investors US
Colorado
+$181M
3
Morgan Stanley
Morgan Stanley
New York
+$156M
4
O
OppenheimerFunds
New York
+$143M
5
Invesco
Invesco
Georgia
+$109M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$496M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$489M
3
TCIM
TIAA CREF Investment Management
New York
-$159M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$119M
5
Citadel Advisors
Citadel Advisors
Florida
-$116M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIM
351
Rainier Investment Management
Washington
– -$52.1M -333,560 Closed
AC
352
Ascend Capital
California
– -$40.5M -259,026 Closed
FIM
353
Foresters Investment Management
New York
– -$38.1M -243,825 Closed
B
354
Baird
Wisconsin
– -$31.8M -203,409 Closed
CCI
355
Columbus Circle Investors
– -$25.6M -163,792 Closed
MCM
356
Marsico Capital Management
Colorado
– -$24.3M -155,723 Closed
LP
357
LMR Partners
United Kingdom
– -$21.9M -140,214 Closed
Voloridge Investment Management
358
Voloridge Investment Management
Florida
– -$21.8M -139,711 Closed
SCM
359
Suvretta Capital Management
New York
– -$20.8M -133,000 Closed
ACPU
360
Arrowgrass Capital Partners (US)
Delaware
– -$20.2M -129,003 Closed
CCM
361
Century Capital Management
Massachusetts
– -$19.1M -122,112 Closed
BLM
362
Bennett Lawrence Management
New York
– -$13.8M -88,435 Closed
IG
363
ING Group
Netherlands
– -$12M -76,600 Closed
PP
364
PDT Partners
New York
– -$11.1M -70,944 Closed
DKCM
365
Davidson Kempner Capital Management
New York
– -$8.59M -55,000 Closed
RAM
366
Riggs Asset Management
Pennsylvania
– -$7.13M -45,649 Closed
LOAMU
367
Lombard Odier Asset Management (USA)
New York
– -$6.8M -43,500 Closed
HH
368
HWG Holdings
Texas
– -$6.19M -39,621 Closed
BNP Paribas Asset Management
369
BNP Paribas Asset Management
France
– -$6.04M -38,686 Closed
GACM
370
Green Arrow Capital Management
New York
– -$4.69M -30,000 Closed
CPC
371
Cookson Peirce & Co
Pennsylvania
– -$3.86M -24,720 Closed
CCM
372
Cupps Capital Management
Illinois
– -$3.81M -24,405 Closed
Connor, Clark & Lunn Investment Management (CC&L)
373
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$3.28M -21,000 Closed
CG
374
Colony Group
Massachusetts
– -$2.86M -18,315 Closed
IHM
375
Iguana Healthcare Management
New York
– -$2.34M -15,000 Closed
13 14
15
16 17

SLXP Hedge Fund Activity: Q4 2014 in Review

346 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2014, worth a combined $7.99B — down 24% from $10.6B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new SLXP positions and 94 closed out — a net gain of 2 holders — while 120 added to existing stakes and 112 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $496M.

  • 346 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2014, down from 348 in Q3 2014.
  • Funds reported $7.99B of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2014, down 24% quarter-over-quarter.
  • 96 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2014 and 94 closed out, a net change of +2 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2014 was Paulson & Co, an estimated $703M added.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q4 2014 was Wellington Management Group, an estimated $496M sold.

Based on aggregated 13F filings for Q4 2014.